On the Go

Emmanuelle Charpentier has always been on the go, the New York Times writes of the Max Planck Institute for Infection Biology researcher of CRISPR/Cas9 genome editing fame. But lately, it adds, it's been less bouncing from position to position as an itinerant researcher to waking up in the middle of the night to work before returning to sleep.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.